Clinical trials
Metabolic Diseases trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 4 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| AstraZeneca | 4 |
| 89bio, Inc. | 3 |
| CENTOGENE GmbH Rostock | 3 |
| Centre for Chronic Disease Control, India | 2 |
| Regeneron Pharmaceuticals | 2 |
| Bayer | 1 |
| GEM Hospital & Research Center | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 27 |
| Diabetes Mellitus, Type 2 | 12 |
| Diabetes Mellitus | 9 |
| Glucose Metabolism Disorders | 9 |
| Endocrine System Diseases | 8 |
| Genetic Diseases, Inborn | 4 |
| Lipid Metabolism Disorders | 3 |
| Liver Diseases | 3 |
| Lysosomal Storage Diseases | 3 |
| Metabolism, Inborn Errors | 3 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.